<title>
Anti-hepcidin therapy for iron-restricted anemias.
</title>

<text>

<abstract>
In this issue of Blood, Cooke et al demonstrate the potential of a fully human anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease (formerly known as “anemia of chronic diseases”).
</abstract>

</text>
